Chugai Pharmaceutical, Chugai Pharmaceutical [clinicaltrials_resource:ba6731498877bfef0c26ed66779be77e]
A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Patients With Chronic Hepatitis C [clinicaltrials:NCT00144469]A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy [clinicaltrials:NCT00144482]A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy [clinicaltrials:NCT00144495]Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA) [clinicaltrials:NCT00144508]Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA) [clinicaltrials:NCT00144521]Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP [clinicaltrials:NCT00144534]Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA) [clinicaltrials:NCT00144560]Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment [clinicaltrials:NCT00144573]Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) [clinicaltrials:NCT00144599]Long-term Treatment Study of MRA for Systemic Juvenile Idiopathic Arthritis (sJIA) [clinicaltrials:NCT00144612]Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) [clinicaltrials:NCT00144625]Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) [clinicaltrials:NCT00144664]Trial of Pegasys® in Patients With Chronic Hepatitis C [clinicaltrials:NCT00245414]A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC) [clinicaltrials:NCT00304551]Clinical Study of R744 to Predialysis Patients [clinicaltrials:NCT00433615]Correction Study of R744 in Renal Anemia Patients on Hemodialysis [clinicaltrials:NCT00433693]Clinical Study of R744 to Peritoneal Dialysis Patients [clinicaltrials:NCT00433849]Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study) [clinicaltrials:NCT00433888]Clinical Study of R744 to Hemodialysis Patients [clinicaltrials:NCT00491868]
responsible party [clinicaltrials_vocabulary:responsible-party]
Chugai Pharmaceutical, Chugai Pharmaceutical [clinicaltrials_resource:ba6731498877bfef0c26ed66779be77e]
Bio2RDF identifier
ba6731498877bfef0c26ed66779be77e
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ba6731498877bfef0c26ed66779be77e
name title [clinicaltrials_vocabulary:name-title]
Chugai Pharmaceutical
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:ba6731498877bfef0c26ed66779be77e
title
Chugai Pharmaceutical, Chugai Pharmaceutical
@en
type
label
Chugai Pharmaceutical, Chugai ...... 731498877bfef0c26ed66779be77e]
@en